[pageLogInLogOut]

#Man-Made Fibers

Kraig Biocraft Laboratories announces production expansion

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced that it is preparing to add a third production facility as part of its plans for rapid expansion of recombinant spider silk production.


Over the past 18 months, Kraig Labs has significantly advanced its production model, opening two rearing centers for recombinant spider silk production. The Company is now opening a third center to expand its capacity further.

The Company reports that it is now well underway in identifying a site for this new facility and anticipates finalizing a location within the next 60 days.

This new facility, like the Company’s existing operations, will be established in one of the world’s leading silk production regions. By situating operations within established silk-growing areas, the Company is able to leverage an experienced workforce, robust infrastructure, and a long-standing tradition of excellence in sericulture.

Kraig Labs’ multi-facility strategy is designed to support continuous production. By building redundancies directly into the production chain, the Company has created a stronger and more resilient foundation to meet the current demand and growing market for its recombinant spider silk materials.

“We are looking now for the site of an additional rearing center in order to further expand our production capacity,” said Kim Thompson, Kraig Labs’ founder and CEO. “We expect to lock in the site within the next 60 days. The goal is to further increase our capacity while building in resilience.”

The addition of this new rearing center represents another milestone in Kraig Labs’ expansion of its production capacity and its plans to bring the performance and sustainability benefits of recombinant spider silk to global markets.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.



More News from Kraig Biocraft Laboratories, Inc.

#Raw Materials

Kraig Biocraft Laboratories to launch operations at new Southeast Asia production facility this week

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces that it will begin operations this week at its newest production facility. This milestone marks the launch of the first full production cycle at the site. This production site was secured earlier this summer through an agreement with a government agency in Southeast Asia.

#Raw Materials

Kraig Biocraft Laboratories successfully completes lab-to-field transition for three new spider silk production strains

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces the successful completion of the first rearing cycles for its three newest recombinant spider silk production strains. These newly developed strains were transitioned from the Company’s R&D program into field production earlier this quarter and have now completed their first rearing cycle, delivering strong performance across key production metrics.

#Raw Materials

Kraig Biocraft Laboratories sets new world record for largest spider silk gene insert into silkworm

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk biotechnology, today announced a groundbreaking scientific achievement in the development of high-performance biomaterials. Kraig Labs successfully engineered the largest known spider silk gene insert into silkworm—nearly doubling the previous record. This breakthrough represents a major step toward creating next-generation spider silk fibers with enhanced strength, flexibility, and performance potential.

#Raw Materials

Kraig Biocraft Laboratories meets its target with largest ever product batch of bam-1 spider silk

Kraig Biocraft Laboratories, Inc., a global leader in engineered spider silk technologies, is thrilled to announce that it has begun production of the largest single batch of BAM-1 recombinant spider silk in the Company’s history. Last year, the Company publicly set a goal of exceeding all of 2024’s production with a single production batch in 2025. Today, Kraig Labs announces it has far exceeded that goal and kept that promise.

More News on Man-Made Fibers

Latest News

#Natural Fibers

38th International Cotton Conference Bremen launches registration and unveils key topics

Participants can now register online for the 38th International Cotton Conference Bremen, which will be held on 25-27 March 2026 at the Haus der Bürgerschaft parliament building on market square. All visitors can look forward to a high-calibre conference programme, numerous additional meetings and a valuable exchange of knowledge and information. The comprehensive range of topics covering the entire value chain will provide practical expertise, address current developments, answer key industry questions, and provide new impetus for the future.

#ITMA Asia + CITME Singapore 2025

Innovation and customer proximity – KARL MAYER’s clear focus makes an impression

ITMA ASIA in Singapore was a resounding success for KARL MAYER, exceeding all expectations. The company welcomed visitors from 39 countries and held around 570 expert discussions. Most guests came from India, followed by China, Indonesia and Pakistan. The exchange with them was both well-founded and targeted. Conversation topics ranged from investment projects and new technologies to opportunities for cooperation and business expansion.

#Recycling / Circular Economy

Nanollose creates the world’s first wearable fashion garment made from liquid waste

Australian-based biomaterial technology company Nanollose Ltd (ASX: NC6) has created the world’s first wearable garment using the company’s eco-friendly Tree-Free Rayon fibre (NullarborTM), sourced from sustainable coconut waste.

#Research & Development

Catching heart disease early with AI-based sensor system

It slips on like a normal vest: Fraunhofer IZM has created a smart sensor system in cooperation with the Charité and the Technical University of Berlin. The vest records a vast array of cardiovascular parameters, which an AI-based system uses to support medical diagnostics and spot potentially dangerous developments.

TOP